Z-0120-2022 Class II Terminated
FDA device recall Z-0120-2022 was initiated by Ortho Clinical Diagnostics Inc on September 10, 2021 and is designated Class II. Reason for recall: VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Quantitative Controls Outside of Expected Control Range, potential for delayed results The recall status is terminated (terminated February 13, 2024). Affected quantity: US: 64 OUS: 200.
Recall Details
- Product Type
- Devices
- Report Date
- October 27, 2021
- Initiation Date
- September 10, 2021
- Termination Date
- February 13, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- US: 64 OUS: 200
Product Description
Reason for Recall
Distribution Pattern
Worldwide Distribution: US (Nationwide) in states of: AL, AR, AZ, CA, CO, DC, FL, ID, KS, KY, LA, ME, MI, MS, MO, NY, TN, TX and WV; and OUS (Foreign) in countries of: Australia, Brazil, Canada, Chile, China, Colombia, India, Japan, Mexico, Singapore, United Kingdom, France, Germany, Italy, Spain, Portugal, Russia, Denmark, Norway, Sweden, Belgium, and The Netherlands.